Legal Guidance and Advocacy for Caregivers of Colorectal Cancer Patients
This study aims to provide legal guidance and advocacy support to caregivers of colorectal cancer patients to help them navigate caregiving challenges.
Legal Services
Caregiver Burden+12
+ Behavior
+ Behavioral Symptoms
Supportive Care Study
Summary
Study start date: September 9, 2025
Actual date on which the first participant was enrolled.This study aims to explore the benefits of offering free legal support to caregivers and patients dealing with colorectal cancer. Since managing this condition can be both financially and emotionally challenging, the trial investigates if early legal assistance can help improve the quality of life for those involved. The focus is on how these services can aid in easing financial stress and enhancing emotional well-being, addressing unmet needs in the caregiving experience. Participants in the study, which include both patients and their caregivers, will receive complimentary and personalized legal services provided by Cancer Legal Care, a nonprofit organization based in Minnesota. These services are intended to assist with any legal issues that might arise during the cancer treatment journey. The study lasts for three months, but participants are welcome to continue accessing legal support even after the study ends. This approach evaluates how feasible and acceptable it is to integrate legal care into the support system for those affected by colorectal cancer.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Colorectal Cancer Patient Inclusion Criteria: * Diagnosis of advanced stage (Stage III or Stage IV) colorectal cancer within the past 3 months. * Initiated or planning to initiate systemic cancer therapy. * Able to identify a caregiver for study participation. * Estimated life expectancy of over 6 months in the opinion of the treating oncologist. * 18 years of age or older at the time of consent. * Able to understand, speak, read, and write in English. * Able to provide voluntary written consent prior to the performance of any research related activity. Caregiver Inclusion Criteria: * 18 years of age or older at the time of consent. * Identified as a caregiver by a colorectal cancer patient. * Able to understand, speak, read, and write in English. * Able to provide voluntary written consent prior to the performance of any research related activity. Exclusion Criteria: * Lacks capacity to consent/diminished capacity to consent.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location